Compare Enphase Energy Inc (ENPH) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs Zimmer Biomet Holdings Inc — how do they compare? Enphase Energy Inc trades at $42.73 (market cap $5.81B), while Zimmer Biomet Holdings Inc trades at $93.11 (market cap $17.44B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 3× Enphase Energy Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals.
| ENPH | ZBH | |
|---|---|---|
Market Cap | $5.81B | $17.44B |
Sector | Technology | Health |
52-Week High | $72.33 | $107.71 |
52-Week Low | $26.12 | $79.58 |
Enterprise Value | $5.46B | $24.49B |
Dividend Yield | — | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $44.985, up 4.47% with a neutral technical signal despite bullish moving averages. The company has beaten earnings expectations for three consecutive quarters, though revenue declined from $2.3B in 2023 to $1.47B in 2025. Analyst sentiment is mixed with 40% buy ratings but a consensus price target of $42.79 below current levels. Recent news highlights product expansions in Europe and Australia alongside ongoing legal scrutiny.
ENPH faces near-term headwinds with declining revenue and compressed margins, but maintains strong profitability metrics and consistent earnings beats. Investment appeal hinges on international growth execution and potential regulatory tailwinds, balanced against competitive pressures and stock volatility. The current valuation at 43.61 P/E requires robust growth reinstatement to justify upside.
Zimmer Biomet (ZBH) trades at $91.03, down 3.24% on the day, with a bullish technical signal from moving averages and neutral oscillators. The stock shows consistent earnings beats in recent quarters, with Q2 2026 results pending. Revenue growth has climbed from $6.9B in 2022 to $8.2B in 2025, though net income margin dipped to 8.56%. Recent corporate developments include a $140M acquisition and expansion in India, supporting long-term growth initiatives.
The outlook remains cautiously optimistic with a consensus price target of $97.67, implying 7% upside. Key opportunities include operational efficiency and market share gains, while risks involve debt levels rising to 32.57% of assets and competitive pressures in medical technology. Earnings on August 5 will be critical for near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
